Testing fractional doses of COVID-19 vaccines [Medical Sciences]

Due to the enormous economic, health, and social costs of the COVID-19 pandemic, there are high expected social returns to investing in parallel in multiple approaches to accelerating vaccination. We argue there are high expected social returns to investigating the scope for lowering the dosage of some COVID-19 vaccines. While...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Economic Sciences, Medical Sciences, Coronavirus (COVID-19) Social Sciences Source Type: research